3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Myelodysplastic Syndromes
2
Leukemia
2
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hodgkin Disease
1
Histiocytosis
1
Hemoglobinuria, Paroxysmal
1
Hemoglobinuria
1
Graft vs Host Disease
1
Congenital Abnormalities
1
Blast Crisis
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Peripheral Blood Stem Cell Transplantation
12
Rituximab
9
Tacrolimus
8
Mycophenolic Acid
8
fludarabine phosphate
7
Cyclophosphamide
7
Whole-Body Irradiation
6
Cyclosporine
5
Radiotherapy
4
Methotrexate
4
Granulocyte Colony-Stimulating Factor
4
Filgrastim
4
Busulfan
4
Antilymphocyte Serum
4
immunotoxin HA22
3
fludarabine
3
Etoposide
3
Dexamethasone
3
Calcium Dobesilate
3
plerixafor
2
merphos
2
Therapeutics
2
Sirolimus
2
Ondansetron
2
Melphalan
2
Ipilimumab
2
Flow Cytometry
2
Diphenhydramine
2
Darbepoetin alfa
2
Cord Blood Stem Cell Transplantation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Hairy Cell
×
Muromonab-CD3
×
Clear all
No trials found.